Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, signaling a minor update to the page’s template or presentation.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page template with likely small fixes or improvements rather than substantive content changes.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating the study page has been updated to the latest revision.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a new page release rather than a change to the study details.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now lists Revision: v3.6.2 as the current document version, replacing Revision: v3.6.0. This indicates an update to the study-related documents linked on the page.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded a recruitment status note indicating the study is no longer enrolling. Added new help sections to guide users on reading the study record and how to join a study.SummaryDifference0.3%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.